Artivion 

$25.62
41
-$0.72-2.73% Thursday 20:00
+$0.00+0%Thursday 20:01After hours

Statistics

Day High
25.61
Day Low
25.52
52W High
48.25
52W Low
19.16
Volume
25,864
Avg. Volume
-
Mkt Cap
1.25B
P/E Ratio
96.36
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 15
$0.03
Sep 15
$0.03
Jun 15
$0.03
Mar 15
$0.03
Dec 14
$0.03
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.28
-0.14
-0.01
0.13
Expected EPS
-0.06125
Actual EPS
N/A

Financials

2.21%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
441.33MRevenue
9.77MNet Income

Analyst Ratings

42.00Average Price Target
The highest estimate is 44.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AORT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a major player in the medical devices sector, offering products that compete directly with Artivion's cardiovascular and neurosurgical devices.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific competes in the cardiovascular market, offering a range of products that overlap with Artivion's offerings.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, directly competing with Artivion's cardiovascular solutions.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers medical devices, including cardiovascular and neuromodulation products, that compete with Artivion's portfolio.
Stryker
SYK
Mkt Cap126.84B
Stryker operates in the medical technology field, offering products that compete with Artivion's surgical solutions and medical devices.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which can overlap with some of Artivion's surgical device offerings.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson's medical devices segment offers a broad range of products that compete across several of Artivion's key areas, including surgery and cardiovascular health.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical specializes in robotic-assisted surgery, competing with Artivion's surgical devices and technologies.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a broad array of medical devices and services that can compete with Artivion's offerings in the healthcare sector.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences offers products in neurosurgery, reconstructive and general surgery, directly competing with some of Artivion's surgical and medical device solutions.

About

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Show more...
CEO
James Patrick Mackin
Employees
1800
Country
United States
ISIN
US2289031005
WKN
000900006

Listings

0 Comments

Share your thoughts

FAQ

What is Artivion stock price today?
The current price of AORT is $25.62 USD — it has decreased by -2.73% in the past 24 hours. Watch Artivion stock price performance more closely on the chart.
What is Artivion stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Artivion stocks are traded under the ticker AORT.
Is Artivion stock price growing?
AORT stock has fallen by -4.3% compared to the previous week, the month change is a -4.76% fall, over the last year Artivion has showed a -41.81% decrease.
What is Artivion market cap?
Today Artivion has the market capitalization of 1.25B
When is the next Artivion earnings date?
Artivion is going to release the next earnings report on October 29, 2026.
What were Artivion earnings last quarter?
AORT earnings for the last quarter are -0.28 USD per share, whereas the estimation was 0 USD resulting in a -11,300% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Artivion revenue for the last year?
Artivion revenue for the last year amounts to 441.33M USD.
What is Artivion net income for the last year?
AORT net income for the last year is 9.77M USD.
Does Artivion pay dividends?
Yes, AORT dividends are paid quarterly. The last dividend per share was 0.03 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Artivion have?
As of September 04, 2026, the company has 1,800 employees.
In which sector is Artivion located?
Artivion operates in the Health & Wellness sector.
When did Artivion complete a stock split?
Artivion has not had any recent stock splits.
Where is Artivion headquartered?
Artivion is headquartered in KENNESAW, United States.